Categories
Patentability Requirements Patents Supreme Court

Professor David Taylor on Patent Eligibility and Investment

The following post comes from Terence Yen, a 4E at Scalia Law and a Research Assistant at CPIP.

files labeled as "patents"By Terence Yen

In his new paper, Patent Eligibility and Investment, Professor David Taylor of the SMU Dedman School of Law explores whether the Supreme Court’s recent patent eligibility cases have changed the behavior of venture capital and private equity investment firms. The paper comes from CPIP’s Thomas Edison Innovation Fellowship program, and it was published in the Cardozo Law Review. The tables referenced in this summary should be credited to his paper, and readers are encouraged to read the original publication for a deeper understanding of his survey results.

Prof. Taylor explains that, since 2010, the Supreme Court has come out with several decisions that have shaken up our understanding of patent eligibility. Not only do the new standards set forth by the Court lack administrability, but they have also created confusion and have far reaching consequences that have drawn concern and criticism from inventors, scientists, lawyers, judges, and industry groups. In fact, these new standards have required lower courts to make determinations of eligibility that the judges themselves recognize as flawed.

As Prof. Taylor explains, the crux of the issue lies in the Supreme Court’s new patentability standard, which requires an inventive application of a newly discovered law of nature, a natural phenomenon, or an abstract idea beyond the mere practical application of such a discovery, as had been previously required. The result is that a scientist cannot obtain a patent for merely making a new discovery (e.g., the cure to cancer) and disclosing how to apply that discovery to advance the state of the world (e.g., treating a patient using the cure). The inventor must additionally include a disclosure of how to apply the new discovery in a new way, creating a double novelty requirement.

Prof. Taylor points to Ariosa Diagnostics v. Sequenom to illustrate some of the issues with this new standard. In Ariosa, scientists discovered that a pregnant woman’s bloodstream included genetic material from her unborn baby. Upon making this discovery, they used known techniques to create methods to use the material to identify fetal characteristics. These new methods were a significant improvement on prior ones, which required the invasive and risky process of taking samples from the fetus or placenta.

The inventors obtained a patent, but the Federal Circuit was forced to invalidate it because the claimed method did not include any inventive concept transforming this natural phenomenon into a patent-eligible invention. In his concurring opinion, Judge Linn condemned the Supreme Court standard, as it required the court to find that an otherwise meritorious invention was ineligible to obtain the protection it deserved. He particularly criticized the second part of the standard, the requirement of an “inventive concept”, which discounts “seemingly without qualification” any conventional or obvious steps in the process.

Many people have criticized this new two-part test and the additional requirement of an “inventive concept.” Indeed, Prof. Taylor previously condemned this standard as reflecting “a lack of understanding of the relevant statutory provisions, precedent, and policies already undergirding the patent statute.” In this new paper, Prof. Taylor seeks to understand how this has impacted investment decisions, and he begins to compile the data largely missing from the existing literature that would start to shed light on the matter.

To gather the relevant data, Prof. Taylor conducted a survey of 475 venture capital and private equity investors from at least 422 different firms representing the various early stages of venture capital funding: early, seed, middle, growth, expansion, and late investors. In general, he asked two types of questions:

    1. Whether the Supreme Court’s rulings on patent eligibility have impacted their decisions to invest in companies developing technology, and if so, how

 

  1. Indirect questions related to the same issue, such as asking about any changes to decisions to invest in companies over the relevant time period, and whether those changes relate to any decreased availability of patent protection

The tables below indicate the different stages of venture capital funding represented by the surveyed firms, as well as the variety of represented industries. The total percentages come out to over 100%, because most firms focused on multiple investment stages and industry areas. It should be noted that the survey questions related only to U.S. patents and only to financing activities in the United States.

Table 1: Investment Stages of Respondents' Firms. Early stage, 59%. Seed stage, 45%. Middle Stage, 27%. Growth Stage, 22%. Expansion stage, 15%. Lat stage, 1%.

Table 2: Investment Industries of Respondents' Firms. Industry to percent. Software and the Internet, 70%. Medical Devices, 63%. Computer Electronics/Hardware, 61%. Biotechnology, 55%. Pharmaceutical, 54%. Communications, 53%. Energy, 49%. Semiconductors, 48%. Transportation, 47%. Construction, 42%.

The Findings

Overwhelmingly, investors reported that patent eligibility is an important consideration for their firms when deciding whether to invest in companies that are developing technology. In total, 74% agreed with this idea, while only 13% disagreed.

Table 7: Patent Eligibility Is an Important Consideration in Firm Decisions Whether to Invest in Companies Developing Technology. Response to percent. Strongly agree, 43%. Somewhat agree, 31%. Neither agree nor disagree, 13%. Somewhat disagree, 9%. Strongly disagree, 5%.

This led to the natural follow-up question: If the laws of patent eligibility make a patent unavailable for a certain technology, would the firm be less likely to invest in companies developing that technology? In response, 62% agreed that their firms would be less likely to invest given the unavailability of patents.

Table 8: Less Likely to Invest if Patent Eligibility Makes Patents Unavailable. Response to percent. Strongly agree, 23%. Somewhat agree, 39%. Neither agree nor disagree, 19%. Somewhat disagree, 13%. Strongly disagree, 7%.

The response changed slightly when the scenario was changed to one where the patent was merely more difficult to obtain. However, there was not a significant change from the response to the previous question, and respondents weighed in at 59% agreement.

Table 9: Less Likely to Invest if Patent Eligibility Makes Patents More Difficult to Obtain. Response to percent. Strongly agree, 19%. Somewhat agree, 40%. Neither agree nor disagree, 18%. Somewhat disagree, 17%. Strongly disagree, 5%.

From the data collected, it appears that investors in the medical device, biotechnology, and pharmaceutical industries tend to value patentability slightly more than investors in the software space. Additionally, early-stage investors seemed to value patent eligibility slightly more than their late-stage counterparts, though there was not a statistically significant difference reported between the different stages of investment. Prof. Taylor theorizes here that a larger sample size might indicate a more obvious trend.

Prof. Taylor notes one interesting statistic: those who were familiar with the Supreme Court’s recent eligibility decisions tended to value patent eligibility higher than those who were not familiar with the cases. This may indicate that the more aware an investor is of the recent opinions, the more they value the impact of those opinions. Prof. Taylor makes sure to note, however, that the data do not preclude the possibility that the more one knows about a subject, the more importance one places on one’s own knowledge of the subject. Additionally, patent eligibility did not appear to be the primary focus for investors. When compared with various other factors typically considered by investment firms, patent eligibility was consistently relegated to a lesser role. It is significant to note that the present survey focused on the availability of patents based only on patent eligibility.

Table 15: Factors Relied upon when Deciding to Invest in Companies Developing Technology: Weighted Mean. Factor to mean (1-9 scale). Quality of People, 7.77. Quality of Technology, 7.55. Size of Potential Market, 7.24. Availability of U.S. Patents, 5.31. First-Mover Advantage, 4.94. Availability of Foreign Patents, 3.72. Availability of Trade Secrets, 3.31. Availability of Copyrights, 3.13. Other, 2.03.

In general, investors indicated that the loss of patent protection would cause them to decrease their investments, though Prof. Taylor finds that this decreased investment would be more pronounced in some industries than others. As shown using weighted averages, the three industries with the greatest reported decrease would be the pharmaceutical, biotechnology, and medical device industries.

Table 18: Impact of Elimination of Patents on Investment Decisions: Responses. Industry to increase or decrease. Construction: Strongly Increase, 1%, Somewhat Increase, 5%, No Impact, 75%, Somewhat Decrease, 14%, or Strongly Decrease, 6%. Software and the Internet: Strongly Increase, 3%, Somewhat Increase, 10%, No Impact, 53%, Somewhat Decrease, 27%, or Strongly Decrease, 8%. Transportation: Strongly Increase, 2%, Somewhat Increase, 7%, No Impact, 53%, Somewhat Decrease, 31%, or Strongly Decrease, 7%. Communications: Strongly Increase, 2%, Somewhat Increase, 8%, No Impact, 48%, Somewhat Decrease, 32%, or Strongly Decrease, 10%. Energy: Strongly Increase, 2%, Somewhat Increase, 4%, No Impact, 49%, Somewhat Decrease, 30%, or Strongly Decrease, 15%. Computer/Electronics Hardware: Strongly Increase, 4%, Somewhat Increase, 6%, No Impact, 33%, Somewhat Decrease, 39%, or Strongly Decrease, 18%. Semiconductors: Strongly Increase, 4%, Somewhat Increase, 3%, No Impact, 33%, Somewhat Decrease, 34%, or Strongly Decrease, 27%. Medical Devices: Strongly Increase, 6%, Somewhat Increase, 3%, No Impact, 11%, Somewhat Decrease, 32%, or Strongly Decrease, 47%. Biotechnology: Strongly Increase, 7%, Somewhat Increase, 2%, No Impact, 14%, Somewhat Decrease, 22%, or Strongly Decrease, 55%. Pharmaceutical: Strongly Increase, 7%, Somewhat Increase, 1%, No Impact, 19%, Somewhat Decrease, 11%, or Strongly Decrease, 62%.

Next, Prof. Taylor explores the impact that the Supreme Court’s decisions have had on investment behaviors. The survey showed that 38% of investors were familiar with at least one of the patent-eligibility cases. About 40% of those knowledgeable investors indicated that the decisions had a negative effect on their firms’ existing investments, compared with 14% who indicated positive effects.

Table 21: Impact of Supreme Court's Eligibility Cases on Existing Investments. Response to percent. Very positive, 1%. Somewhat positive, 13%. No Impact, 46%. Somewhat negative, 33%. Very negative, 7%.

However, Prof. Taylor notes that these numbers represent only the static impact of the Supreme Court cases. Dynamic impact—meaning, the impact on future decision making—is likely the more important statistic. Interestingly, only one-third of investors indicated that the cases would impact their decisions on whether to invest in companies going forward, with no statistically significant difference based on industry or stage of funding.

Table 22: Have Any of the Supreme Court's Eligibility Cases Affected Firm Decisions Whether to Invest in Companies. Yes, 33%. No, 61%. Don't know, 6%.

With the numbers above representing investors with knowledge of the patent eligibility cases, it should be no surprise to learn that investors unfamiliar with the Supreme Court cases overwhelmingly responded that the decreased availability of patents had not impacted their firms’ changes in investment behavior.

Table 28: Has Decreased Availability of Patents Since 2009 Contributed to Your Firm's Change in Investments (Unknowledgeable Investors Only). Type of change to reply percentage. No change: Yes, 2%; No, 95%; Don't Know, 4%. Increased investments overall: Yes, 0%; No, 88%; Don't Know, 12%. Decreased investments overall: Yes, 14%; No, 82%; Don't Know, 5%. Shifted investments between industries: Yes, 4%; No, 84%; Don't Know, 12%.

Conclusion

While there were a wide variety of opinions from the many investors regarding the current state of patent eligibility, the general consensus was that the Supreme Court’s decisions have had a negative impact on patentability, leading to a potential decrease in a willingness to invest. This attitude was most prevalent in, but not limited to, the biotechnology and pharmaceutical industries.

As presented in his paper, Prof. Taylor’s survey provides the first empirical data on how the current state of patent eligibility has affected the attitude of investors. Like all surveys, however, it is susceptible to a certain degree of error caused by various unavoidable human characteristics. Even recognizing its limitations, this survey provides useful information that can be used to begin analyzing the question of whether the Supreme Court’s eligibility cases have impacted investment decision making, and it sheds light on an issue about which many experts in the field have become increasingly concerned.

Categories
Copyright

Copyright Notebook: The Importance of Artists’ Agency

the word "copyright" typed on a typewriterI am looking forward to hosting a keynote conversation with Grammy-winning composer, performer, songwriter, best-selling author, and essayist Rosanne Cash this week at CPIP’s The Evolving Music Ecosystem conference. One part of Rosanne Cash’s “music ecosystem” is the Artist Rights Alliance (ARA), where she serves as a member of the board. Preparing for that conversation, I am thinking a lot about the importance of artists’ agency. Over the summer, the ARA “rebooted,” relaunching itself with a powerhouse music council of artists and experts. The ARA is “an alliance of working musicians, performers, and songwriters fighting for a healthy creative economy and fair treatment for all creators in the digital world. [They] work to defend and protect artists, guided by [their] Artists’ Bill of Rights, which outlines fundamental principles for today’s music economy.”

Those principles:

The Right to Control Our Work
The Right to Economic and Artistic Freedom
The Right to Attribution and Acknowledgment
The Right to a Music Community
The Right to Competitive Platforms
The Right to Information and Platform Transparency
The Right to Political Participation

 

All share one core attribute—an artist’s agency—over their work, their livelihood, their community, themselves. That the ARA found it necessary to relaunch this summer is not surprising. The triple threat of a pandemic decimating artists’ livelihoods, the surging power of technology platforms, and the challenges of ensuring one’s work is not distorted by others or used to send disagreeable political messages has heightened awareness among artists about the issues for which ARA stands.

Several notable lawsuits have also brought these issues to the forefront this summer that may shape the nature of artists’ agency over their work for years to come. Here are some thoughts about why they are significant and some issues you may not have noticed.

Hachette Book Group et al. v. Internet Archive

On June 1, 2020, four of the world’s preeminent publishing houses sued Internet Archive (IA) for willful mass copyright infringement. The IA styles itself an online library, open to anyone to borrow books, music, and other works. It scans millions of copyrighted as well as public domain works and makes them available to “borrowers” for free. It had previously operated under an already controversial policy of “controlled digital lending” (more on that below), but in response to the COVID-19 pandemic, dropped even these minimal restrictions on its distribution of works. As the Authors Guild put it in an open letter to the IA:

[B]y declaring a spurious “copyright emergency” and making a massive trove of copyrighted books available for free without any restrictions, Internet Archive has demonstrated a shocking disrespect for the rule of law—the cornerstone of our civil, democratic society—at a time when we most need it to prevail. You cloak your illegal scanning and distribution of books behind the pretense of magnanimously giving people access to them. But giving away what is not yours is simply stealing, and there is nothing magnanimous about that. Authors and publishers—the rights owners who legally can give their books away—are already working to provide electronic access to books to libraries and the people who need them. We do not need Internet Archive to give our works away for us.

 

In their complaint, the publishers argue that IA’s assertion that it should not be liable for infringement is based on “an invented theory called ‘Controlled Digital Lending’ (‘CDL’)—the rules of which have been concocted from whole cloth and continue to get worse.” As the complaint sets forth:

[A]t first, under this theory IA claimed to limit the number of scanned copies of a title available for free download at any one time to the number of print books of that title in its collection—though no provision under copyright law offers a colorable defense to the systematic copying and distribution of digital book files simply because the actor collects corresponding physical copies. Then, in the face of the COVID-19 pandemic, IA opportunistically seized upon the global health crisis to further enlarge its cause, announcing with great fanfare that it would remove these already deficient limitations that were purportedly in place. Today, IA offers an enormous universe of scanned books to an unlimited number of individuals simultaneously in its “National Emergency Library.” IA’s blatant, willful infringement is all the more egregious for its timing, which comes at the very moment that many authors, publishers, and independent bookstores, not to mention libraries, are both struggling to survive amidst economic uncertainty, and planning deliberatively for future, changing markets.

 

The publishers’ lawsuit is important because it is the first “live” judicial challenge to the legal theory of “controlled digital lending”—a legal theory which was announced by certain academics and internet advocates in 2018. They argue that it should be fair use for libraries to scan or obtain scans of physical books they own and lend them electronically, provided certain restrictions are applied, such as limitations that attempt to emulate the limitations of lending in the physical world (e.g., limits on lending periods and on numbers of copies that can be loaned at a given time).

I refer to this as the first “live” judicial challenge because, while it is the first time CDL has been challenged in the courts, the supporters of CDL sought and failed to receive the blessing of the Second Circuit for IA’s original Open Library service when that court was reviewing the decision in Capitol Records v ReDigi. Unsurprisingly, the court declined to do so. In an opinion written by Judge Leval, the Second Circuit rejected ReDigi’s and its amici’s fair use argument because market harm would be likely since the sales of ReDigi’s digital files would compete directly with those of Capitol Records. Because “used” digital files do not deteriorate like used physical media, there would be no reason for customers to buy new licenses from Capitol Records if they could obtain the files from ReDigi at a lower price.

One imagines that the impact of free CDL on e-book sales would only be worse—first, because it is free, rather than merely a reduced price for “used” files, and second, because it would be usurping a valuable market authors and publishers have continued to actively develop and license for several years since the ReDigi decision. This includes licensing to libraries for free lending via services like OverDrive. It is likewise significant that the “Emergency Library” at issue in the publishers’ case against IA is far less restricted than the version of IA’s “Open Library” the amici sought and failed to have blessed by the Second Circuit in ReDigi.

Maria Schneider et. al. v. YouTube

Another case to watch is the class action lawsuit filed by composer and jazz performer Maria Schneider against YouTube and its parent companies Google and Alphabet in July. The lawsuit alleges that “YouTube has facilitated and induced [a] hotbed of copyright infringement [on its website] through its development and implementation of a copyright enforcement system that protects only the most powerful copyright owners such as major studios and record labels.” Because members of the class are denied access to the copyright management tool YouTube offers its corporate partners—Content ID—the lawsuit alleges that rather than preventing repeat infringements of works, the tool “actually insulates the vast majority of known and repeated copyright infringers from YouTube’s repeat infringer policy, thereby encouraging its users’ continuing upload of infringing content.”

This is all part of a deliberate strategy, according to the complaint:

Defendants Alphabet, Google, and YouTube reap billions of dollars annually from the online hosting of videos, including millions of works that infringe on the exclusive copyrights of Plaintiffs and the Class. Defendants permit and facilitate this infringement because it furthers their growth and revenue strategies and because they have determined that Plaintiffs and the Class—unlike YouTube’s preferred Content ID partners—lack the resources and leverage necessary to combat copyright infringement on the scale at which it is perpetuated on YouTube.

 

Maria Schneider argues many of the same things she and other artist advocates have asserted before Congress, the U.S. Copyright Office, and the U.S. Patent and Trademark Office in hearings and roundtable proceedings exploring the provisions of Section 512 of the Digital Millennium Copyright Act (DMCA):

Faced with litigation by major music studios and other significant rights holders, Defendants have crafted distinct and disparate systems of copyright “enforcement” on their platform. For those entities with vast stores of copyright material and thus the leverage to require Defendants to appease their copyright management concerns, YouTube created its Content ID program, which allows qualifying copyright owners automatically to identify and manage their content on YouTube. . . . Smaller rights holders, including [Schneider], are, however, denied access to Content ID and thus are relegated to vastly inferior and time-consuming means of trying to police and manage their copyrights such as scanning the entirety of YouTube postings, searching for keywords, titles, and other potential identifiers.

 

They must then send notices identifying infringements URL by URL, filling out cumbersome webforms, often laden with advertising, struggle with captcha codes, and contend with requests for additional information or challenges from employees reviewing the requests.

While many artists have neither the pocketbook nor the backbone to stand up to an adversary like YouTube in federal court, this lawsuit seems particularly well-timed given that the ongoing focus on Section 512 in multiple government venues over the past decade has developed a solid record articulating the scope and the magnitude of the problem, as well as that the complaints against YouTube and other web platforms by individual artists seem to be almost universally shared.

Regardless of Maria Schneider’s lawsuit, the Senate and the U.S. Copyright Office are not done considering the issue. The Copyright Office released its much-anticipated Section 512 Report earlier this May and engaged in a subsequent exchange of letters with Senators Thom Tillis and Patrick Leahy regarding additional statutory clarifications that the Senate might consider and other approaches that could improve the operation of the DMCA without legislative amendment. Among the issues addressed in that letter is a request from the Senators to the Copyright Office to conduct stakeholder meetings to identify and adopt standard technical measures (STMs) as was anticipated in Section 512(i) of the DMCA. It is notable that Maria Schneider has herself been an active participant in the Copyright Office’s Section 512 proceedings, and in February of 2017, she submitted comments to the Copyright Office urging that Content ID be recognized as a STM under the DMCA and that all creators be granted access to it in order to be able to more efficiently police YouTube’s platform. The Copyright Office did not take up her suggestion.

In answer to the Tillis/Leahy request, on June 29, 2020, the Copyright Office responded in part that it will convene virtual meetings in late summer/early fall “focused on identifying any potential obstacles to the identification of potential STMs, as well as the requirements that must be met in order to adopt and implement an STM,” and to “begin identifying the kinds of technologies that may meet the statutory definition. Once the bounds of potential qualifying technologies have been identified, the Office would then convene further discussion to evaluate whether individual technologies meet the other requirements of section 512(i), including discussions to learn more about the terms upon which the technologies are offered in the marketplace.”

To date, hypothetical discussions (as well as lawsuits and licensing) have focused on digital fingerprinting technologies. Such technologies are designed to identify content by taking a “fingerprint” of a file that is being or has been uploaded to a platform and matching it to a database of sample content submitted by copyright owners. Regardless of the technology identified as an STM, the challenge may come not from choosing the technology, but rather in applying it. What one copyright owner is willing to tolerate in the name of marketing and fan word of mouth, another will not be. What a technology platform may set the technology to overlook, a filmmaker on the eve of a festival premiere will consider a “match.” Hence the importance of artists’ agency. Or as the ARA would have it: the right to competitive platforms and the right to information and platform transparency. Unless artists are informed about the STMs platforms apply and how they apply them, and unless they have the ability to keep their work from platforms that don’t meet their requirements, identifying an STM on its own won’t make much of a difference. Without artists’ agency and the right to control what happens to their creative output, we may just have the digital fingerprint version of the notice-and-takedown “whack-a-mole” game.[1]

Neil Young v. Donald J. Trump for President

Musicians have perpetually battled with political campaigns over the unauthorized use of their music at rallies and other campaign events. Given the particularly heated nature of this year’s presidential contest, it is perhaps not surprising that Neil Young has sued the Trump campaign for copyright infringement for publicly performing his musical works Rockin’ in the Free World and Devil’s Sidewalk at numerous campaign rallies and events, including one in Tulsa, Oklahoma. The complaint alleges: “The Campaign has willfully ignored Plaintiff’s telling it not to play the Songs and willfully proceeded to play the Songs despite its lack of a license and despite its knowledge that a license is required to do so.”

Neil Young is not the only musician battling the Trump campaign. Leonard Cohen’s estate is considering whether to file suit for the campaign’s use of Halleluiah during the last night of the Republican National Convention, and the Rolling Stones are working with ASCAP and BMI to persuade the Trump campaign to stop playing You Can’t Always Get What You Want at rallies. Campaigns typically assert that they are permitted to play any songs included in the Performing Rights Organizations’ political entities licenses, from which artists may seek to exclude their works if they object to use at political rallies. The allegations by Neil Young, the Cohen estate, and the Stones seem to be that the particular uses by the Trump campaign have gone beyond what a venue license for a political gathering envisions and that the campaign is instead using the songs to either distort their meaning or suggest an endorsement by the artist.

As the members of the Artist Rights Alliance wrote to all of the Republican and Democratic National Campaign Committees this July: “Like all other citizens, artists have the fundamental right to control their work and make free choices regarding their political expression and participation. Using their work for political purposes without their consent fundamentally breaches those rights—an invasion of the most hallowed, even sacred personal interests.”

These lawsuits are interesting because, until now, due to a combination of the veneer of protection offered by the venue licenses, and the time constraints imposed by campaign season, the only viable mechanism for discouraging unwanted uses of an artist’s work by a campaign has been public shaming via social media or statements by the artist publicly disowning and rejecting the candidate. Consequently, neither the moral rights or right of publicity-like qualities of the complaints nor the availability of damages for the infringing use have been explored. Since the Trump campaign is unlikely to settle a lawsuit, this case may define the boundaries of political entities licensed uses or add a new tool to musicians’ arsenals in ensuring they are not unwillingly conscripted into the service of a campaign they do not support.

RIP Matt Herron[2]

A civil rights era photographer I admired and came to know when I was CEO of the Copyright Alliance—Matt Herron—recently passed. Matt was inspiring on many levels. He described himself as an “activist with a camera,” and he covered some of the most meaningful moments in the effort to gain voting rights for Black people in the 1960s—including the Selma to Montgomery march.

“I photograph things I believe in. I try to photograph the things that are important in my life,” said Herron during a panel I moderated in 2011. He felt so strongly about what he saw happening in the 1960s south that he picked up his family and moved from Philadelphia to Mississippi because he thought they could be more relevant there. In doing so, through his photographs, he gave countless generations a front row seat to history. He described the five days he spent documenting the march from Selma to Montgomery:

As photographers, we are mostly voyeurs. We stand a little bit aside from an event. Part of our mind is clicking through F Stops and the rest of it is trying to figure out where images and angles are. But sometimes something happens that sucks us in and we lose that voyeuristic element and become part of the event itself. Certainly for me, the Selma March—five  days of walking in rain and sunshine and all kinds of conditions—was one of those moments. I have no memory of where I slept, what I ate, how I handled any of my basic physical problems. All I remember is the camera, the walking, and the faces.

 

Matt Herron lived by the copyright of his photographs and used them to further education about the social causes he covered. Besides the Selma march, he shot whaling protests by Greenpeace and the AIDS quilt. He explained that copyright laws help him keep collections of his images together and allow him to present them for the benefit of the causes covered:

I’ve put some effort into making not just single photographs but collections. I have historical collections and copyright allows me to decide how these images will be presented and how these historical moments can be disseminated. If I didn’t own the copyright some of these pictures of Martin Luther King might be used to advertise shoes. As it is, I can disseminate these images in ways that add to our national heritage, in educational ways for school children and to preserve a piece of history. Copyright allows me to retain this control not so I can keep them to myself but present them to the world in a way that’s coherent.

 

Matt Herron’s lifetime of work demonstrates in a way that is perhaps clearer this summer than any in recent memory why ensuring that artists are guaranteed agency over their creative output—whether they be photographers chronicling our history, musicians expressing our yearning, or authors giving words to our conscience—is crucial to democracy.

[1] Although it is approximately a decade old, this article, The (Im)possibility of “Standard Technical Measures” for UGC Websites, written by then student, now partner at Wilson Sonsini, Lauren Gallo, is the most thorough, balanced, and articulate examination of the issues the USCO is undertaking to date. Gallo notes that already in 2011 when her note was published, rights owners and UGC service providers were deploying fingerprinting technology to protect copyrighted works on the internet and operate repeat infringer policies. She writes: “In light of the widespread use of this successful technology and Congress’ mandate that ‘standard technical measures’ be developed ‘expeditiously,’ individual or infrequent holdouts should not obstruct the consensus necessary to define the term. . . . [F]ingerprinting technology should qualify as ‘standard technical measures’ under section 512(i), so that right holders and service providers may be on notice of their statutory obligations and may continue to develop ‘best practice’ applications for that technology.”

Ms. Gallo’s current practice focuses on novel legal questions online, involving among other issues, the Digital Millennium Copyright Act, and she has represented Google and YouTube in cases challenging their decisions regarding whether or not to remove or limit access to online content.

[2] Portions of this section appeared as a blog post in June of 2011 on the Copyright Alliance website, when I was CEO of that organization.

Categories
Patent Law

Mark Schultz: Weaker Patent Protection Leads to Less Venture Capital Investment

The following post comes from David Ward, a 2L at Scalia Law and a Research Assistant at CPIP.

a lit lightbulb shatteringBy David Ward

Venture capitalists pouring money into a small startup has become a sort of new American Dream for many innovators. The success stories of big American companies starting with nothing more than an idea have pervaded their way into pop culture, inspiring TV shows, movies, and the like. However, CPIP Senior Scholar Mark Schultz has released a new report for USIJ entitled The Importance of an Effective and Reliable Patent System to Investment in Critical Technologies showing that this dream may be harder to attain today due to recent shifts that have weakened the patent system and driven away venture capital investment.

Background

There has been an ongoing debate in the past two decades about whether patents should be stronger or weaker. Proponents of stronger and more effective patents have made the case that they are more valuable, incentivizing investors and innovators to fund and create valuable innovations. On the flip side, critics of the patent system have stated that stronger patents inhibit innovation since they create a web of restrictions and licenses, inhibiting access to important innovations.

This ongoing debate has resulted in several landmark changes to our patent laws and rules in recent years. Prof. Schultz points out several key changes:

These changes have weakened patents by making them easier to challenge, less accessible for smaller companies, and harder to obtain overall. However, with all these changes, there is now data to explore whether weaker patents really do allow for more innovation as patent critics have contended.

Weak Patents Don’t Attract Funding

The short answer is the data doesn’t support the patent critics’ contention that weaker patents clear the way for more innovation because investors no longer see many patent-intensive industries as a good investment. From 2004 to 2017, the share of funding received in patent-intensive industries dropped from over 50% to about 28%. Prof. Schultz is cognizant of the fact that correlation is not causation, but there is an ever-growing pile of evidence that points to one simple explanation: weaker patents result in less funding for innovation.

Patents and intellectual property are critical to venture capitalists (VCs) who want more certainty of a return on their investments. Pending patents that have a lower chance of being granted or patents that could be challenged at any moment create uncertainty for both the patents’ validity and the future costs of litigation. Hence, the weaker patent laws of recent years have led to a decrease in funding for many patent-heavy sectors.

Prof. Schultz’s report doesn’t just rely on the data to reach this conclusion. It also includes several case studies, surveys, and interviews with innovators and investors alike. Perhaps the most telling is a survey by Prof. David Taylor of SMU Law investigating how recent patent cases changed VC and private equity behavior. Of the 475 investors surveyed, 74% said that patent eligibility is an important consideration in firms’ investment decisions, and 62% said that their firms were less likely to invest if patent eligibility changes make patents unavailable. Almost one-third of investors who knew about recent court decisions said it had affected investment decisions away from biotech, medical devices, and pharmaceuticals.

The data again backs this up, as Prof. Schultz’s report shows that those industries have seen some of the biggest loses in VC funding since 2004. In a world where biotech, medical devices, and pharmaceuticals could quite literally be the most important sectors needing innovation and funding to tackle the COVID-19 pandemic, this is less than ideal. Typically, medical treatments cost hundreds of millions of dollars and have a 10-year road ahead of them. The prospect of reaching the end of the road without being able to protect the investment with a strong and effective patent has spooked many investors to other sectors. As a result, there has been less innovation in live-saving treatments, and more of a focus on safer, quality-of-life investments.

Looking Ahead

There is some trend in the positive direction, however. Prof. Schultz notes that USPTO Director Andrei Iancu has demonstrated strong support for the role of patents in the economy with several policy changes aimed at strengthening patent protection. It is also of note that many policymakers are realizing the changes have gone too far, and there are now several pending legislative proposals aimed at fixing these issues. These realizations, coupled with Prof. Schultz’s quantitative and qualitative data, paint a clear picture that all but proves a single point: strong patents promote innovation more than weaker patents. In the words of Prof. Schultz: “Society needs its most successful people working on its most compelling problems. The patent system should support such work.”

To read the report, please click here.

Categories
Biotech Commercialization Conferences Copyright Innovation Intellectual Property Theory Inventors Uncategorized

The Common Economic Case for Patents and Copyrights

This is the second in a series of posts summarizing CPIP’s 2014 Fall Conference, “Common Ground: How Intellectual Property Unites Creators and Innovators.” The Conference was held at George Mason University School of Law on October 9-10, 2014.  Videos of the conference panels and keynote will be available soon.

The opening panel of CPIP’s 2014 Fall Conference examined the common economic case for patents and copyrights. Unfortunately, IP policy discussions often include a false narrative that intellectual property produces monopolies that harm innovation and economic growth.  The panelists, Troy Dow (Disney), Professor Stan Leibowitz (University of Texas at Dallas), Jon Santamauro (Abbvie), and Professor Jay Kesan (University of Illinois College of Law), highlighted how this narrative, in fact, ignores the essential role that intellectual property serves in enabling the creation, development, and commercialization of both inventions and creative works.

Kesan explained how patents provide economic benefits from both an ex-ante and ex-post perspective. Ex-ante, a strong patent system provides incentives to create, invest in R&D, and finance further innovation. While there are other ex-ante motivations to invent (such as a first mover advantage, the ability to secure trade secrets, and reputational advantages), Kesan argued that innovation is best facilitated ex-ante by a combination of all of these incentives plus the incentives created by patents. The ideal system incorporates a heterogeneous mix of these incentives to invent—in the absence of patents the level of disclosure decreases and innovation slows down.

Patents also provide numerous ex-post benefits. Patents facilitate coordination with producers and perform important signaling functions. They additionally allow for important private ordering by giving inventors increased control over who uses their invention and under what circumstances. In many industries, this is essential to collaboration, interoperability of products, and the aggregation of complementary benefits.

Jon Santamauro discussed the role of patents in the pharmaceutical industry. The exclusive property rights created by patents encourage R&D and serve as a crucial catalyst for new discoveries and businesses.  Patent protection is particularly important in the pharmaceutical industry due to the high-risk, lengthy, and costly process necessary to develop new, safe, and effective drugs.

Pharmaceutical companies developing new drugs screen thousands of potential compounds over 6-7 years of testing to gain FDA approval, at an average cost of about $1.2 billion per drug. The reasons for the high R&D costs?  Out of 10,000 initial molecules tested, only 6 go to clinical trials, and of these, only 1 is approved by the FDA for use in the healthcare market.  Of the 1 out of 10,000 drugs that make it to market, only 2 out of every 10 medicines produce enough revenues to recoup the initial high costs of R&D and also provide revenue to invest in more R&D. In short, pharmaceutical and biotech firms face very high risk—high R&D expenditures and very few market successes.  Strong IP protection helps offset this risk and encourages further investment and research.

Leibowitz explained that one of the primary criticisms of copyright—that it grants a monopoly, and that monopolies are intrinsically bad for society—is utterly thoughtless. A property right is, by definition, a monopoly of sorts. This criticism is an indictment of property rights on the whole, including real property rights.  This is even more inapt to copyright, as copyright does not restrict entry and does not provide an economic monopoly.

Leibowitz also addressed the common argument that IP isn’t necessary because inventors and creators would continue inventing and creating even if they didn’t get to own the fruits of their productive labors.  While some innovative and creative activity would undoubtedly continue, many innovators and creators do not simply create for creations sake. They need salaries (like everyone else), and strong IP rights allow them to capture the value of what they produce.

Finally, Troy Dow highlighted the benefits of strong copyright protection in the movie industry. Bringing a film to market involves substantial risks that many people do not appreciate.  He explained that studios perform the same market function as venture capitalists: they invest in  films at the birth of the original idea and then provide financing all the way through the final showing in movie theaters. This financing comes from banks, other investors, or other studios in order to spread the risk. Dow analogized a new film project to a new startup company, as each new film has its equivalent of a CEO (producer), COO (director), and thousands of employees and independent contractors.  And just as with startup companies, everyone must be paid before the film makes a single cent in revenue.

A single film can cost over $200 million to produce. While a particularly big hit can gross over $350 million after long-term distribution (including on-demand and DVD sales), only 4 out of every 10 movies recoup their investment at the box office. Copyright thus serves the vital function of making it possible for studios to make substantial, upfront investments with the hope of a return on this investment and a sufficient profit to reinvest in further film projects.

Disney’s IP is enormously valuable and is the dominant driver of their business. Even though only $6 billion of Disney’s $45 billion in revenues last year came directly from movie revenue, the movies, including the stories they tell, are at the heart of the Disney experience.  The movies form the basis for other products, media networks, theme parks, and licensing. A strong copyright regime allows studios like Disney to keep producing both creative works and the myriad other products and experiences that so many of us enjoy.

Together, the four panelists illustrated that the economic foundations of IP are equally applicable to the creative industries as they are to the innovation industries.  By securing for inventors and creators the value of their productive labors, IP provides the economic bedrock of our creative and innovative economy.